KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $40.0 billion.

  • Merck's Non-Current Debt rose 1425.59% to $40.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 billion, marking a year-over-year increase of 1425.59%. This contributed to the annual value of $34.5 billion for FY2024, which is 231.27% up from last year.
  • As of Q3 2025, Merck's Non-Current Debt stood at $40.0 billion, which was up 1425.59% from $34.0 billion recorded in Q2 2025.
  • Merck's 5-year Non-Current Debt high stood at $40.0 billion for Q3 2025, and its period low was $22.9 billion during Q3 2021.
  • Moreover, its 5-year median value for Non-Current Debt was $31.1 billion (2024), whereas its average is $31.1 billion.
  • In the last 5 years, Merck's Non-Current Debt tumbled by 1297.06% in 2021 and then soared by 2743.1% in 2022.
  • Merck's Non-Current Debt (Quarter) stood at $30.7 billion in 2021, then decreased by 6.34% to $28.7 billion in 2022, then grew by 17.18% to $33.7 billion in 2023, then increased by 2.31% to $34.5 billion in 2024, then rose by 15.98% to $40.0 billion in 2025.
  • Its Non-Current Debt was $40.0 billion in Q3 2025, compared to $34.0 billion in Q2 2025 and $33.5 billion in Q1 2025.